Evidence-based medicine, systematic reviews, and guidelines in interventional pain management: Part 4: Observational studies

Pain Physician

Volumn 12, Issue 1, 2009, Pages 73-108

  Manchikanti, Laxmaiah ^a,e   Singh, Vijay ^b   Smith, Howard S ^c   Hirsch, Joshua A ^d  

^a PAIN MANAGEMENT CENTER OF PADUCAH   (United States)

^b Pain Diagnostics Associates   (United States)

^c ALBANY MEDICAL COLLEGE   (United States)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

^e NONE   (United States)

Author keywords

Allocation bias; Case control studies; Cohort studies; Cross sectional studies; Observational studies; Sample size; Strengthening of the Reporting of Observational Studies in Epidemiology (STROBE)

Indexed keywords

PLACEBO;

CLINICAL RESEARCH; COHORT ANALYSIS; DATA EXTRACTION; EVIDENCE BASED MEDICINE; METHODOLOGY; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PAIN; PRACTICE GUIDELINE; QUALITY CONTROL; RELIABILITY; REVIEW; SAMPLE SIZE; SAMPLING ERROR; SENSITIVITY ANALYSIS; STATISTICAL ANALYSIS; SYSTEMATIC ERROR; HUMAN; OBSERVATION; STANDARD;

EVIDENCE-BASED MEDICINE; GUIDELINES AS TOPIC; HUMANS; OBSERVATION; PAIN;

EID: 63249122723     PISSN: 15333159     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (358)

1. Guyatt G, Drummond R. Part 1. The Basics: Using the Medical Literature. 1A. Introduction: The philosophy of evidence-based medicine. In: Users' Guides to the Medical Literature: A Manual for Evidence-Based Clinical Practice. American Medical Association, Chicago, 2002, pp 3-12.
2. Napodano RJ. Values in Medical Practice. Human Sciences Press, New York, 1986.
3. Haynes RB, Sackett RB, Gray JM, Cook DC, Guyatt GH. Transferring evidence from research into practice: 1. The role of clinical care research evidence in clinical decisions. ACP J Club 1996; 125:A14-A16.
4. Vandenbroucke JP, von Elm E, Altman DG, Gøtzsche PC, Mulrow CD, Pocock SJ, Poole C, Schlesselman JJ, Egger M, STROBE Initiative. Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): Explanation and elaboration. Ann Intern Med 2007; 147: W163-W194.
5. von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP, STROBE Initiative. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for reporting observational studies. Ann Intern Med 2007; 147:573-577.
6. Healy D. Randomized Controlled Trials: Evidence Biased Psychiatry. Alliance for Human Research Protection, 2002. www.ahrp.org/COI/ healy0802.php
7. Hotopf M. The pragmatic randomized controlled trial. Adv Psychiatr Treat 2002; 8:326-333.
8. Williams DD, Garner J. The case against "the evidence": A different perspective on evidence-based medicine. Br J Psychiatry 2002; 180:8-12.
9. Hotopf M, Lewis G, Normand C. Putting trials on trial: The costs and consequences of small trials in depression: A systematic review of methodology. J Epidemiol Community Health 1997; 51:354-358.
10. Thornley B, Adams C. Content and quality of 2, 000 controlled trials in schizophrenia over 50 years. BMJ 1998; 317:1181-1184.
11. Hotopf M, Churchill R, Lewis G. Pragmatic randomized controlled trials in psychiatry. Br J Psychiatry 1999; 175:217-223.
12. Miles A, Charlton B, Bentley P, Polychronis A, Grey J, Price N. New perspectives in the evidence-based healthcare debate. J Eval Clin Pract 2000; 6:77-84.
13. Glasziou P, Vandenbroucke JP, Chalmers I. Assessing the quality of research. BMJ 2004; 328:39-41.
14. Black N. Why we need observational studies to evaluate the effectiveness of health care. BMJ 1996; 312:1215-1218.
15. Funai EF, Rosenbush EJ, Lee MJ, Del Priore G. Distribution of study designs in four major US journals of obstetrics and gynecology. Gynecol Obstet Invest 2001; 51:8-11.
16. Scales CD Jr., Norris RD, Peterson BL, Preminger GM, Dahm P. Clinical research and statistical methods in the urology literature. J Urol 2005; 174:1374-1379.
17. Greene T. Are observational studies "just as effective" as randomized clinical trials? Blood Purif 2000; 18:317-322.
18. Papanikolaou PN, Christidi GD, Ioannidis JP. Comparison of evidence on harms of medical interventions in randomized and nonrandomized studies. CMAJ 2006; 174:635-641.
19. Hempel CG. Philosophy of Natural Science. Prentice-Hall, Englewood Cliffs, 1966.
20. Popper KR. The Logic of Scientific Discovery. Cambridge University Press, London, 1958.
21. Altman DG, Schulz KF, Moher D, Egger M, Davidoff F, Elbourne D, Gøtzsche PC, Lang T; CONSORT GROUP (Consolidated Standards of Reporting Trials). The revised CONSORT statement for reporting randomized trials: Explanation and elaboration. Ann Intern Med 2001; 134:663-694.
22. Piaggio G, Elbourne DR, Altman DG, Pocock SJ, Evans SJ; CONSORT Group. Reporting of noninferiority and equivalence randomized trials: An extension of the CONSORT statement. JAMA 2006; 295:1152-1160.
23. Deeks JJ, Dinnes J, D'Amico R, Sowden AJ, Sakarovitch C, Song F, Petticrew M, Altman DG; International Stroke Trial Collaborative Group; European Carotid Surgery Trial Collaborative Group. Evaluating non-randomised intervention studies. Health Technol Assess 2003; 7:1-173.
24. Pocock SJ, Collier TJ, Dandreo KJ, de Stavola BL, Goldman MB, Kalish LA, Kasten LE, McCormack VA. Issues in the reporting of epidemiological studies: A survey of recent practice. BMJ 2004; 329:883.
25. Juni P, Altman DG, Egger M. Systematic reviews in health care: Assessing the quality of controlled clinical trials. BMJ 2001; 323:42-46.
26. Egger M, Schneider M, Davey Smith G. Spurious precision? Meta-analysis of observational studies. BMJ 1998; 316:140-144.
27. Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, Moher D, Becker BJ, Sipe TA, Thacker SB. Metaanalysis of observational studies in epidemiology: A proposal for reporting. Meta-analysis of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000; 283:2008-2012.
28. Bero LA, Jadad AR. How consumers and policy makers can use systematic reviews for decision making. Ann Intern Med 1997; 127:37-42.
29. Berlin JA, Rennie D. Measuring the quality of trials. JAMA 1999; 282:1083-1085.
30. Blettner M, Sauerbrei W, Schlehofer B, Scheuchenpflug T, Friedenreich C. Traditional reviews, meta-analyses and pooled analyses in epidemiology. Int J Epidemiol 1999; 28:1-9.
31. Radford MJ, Foody JM. How do observational studies expand the evidence base for therapy? JAMA 2001; 286:1228-1230.
32. Lee W, Bindman J, Ford T, Glozier N, Moran P, Stewart R, Hotopf M. Bias in psychiatric case-control studies: Literature survey. Br J Psychiatry 2007; 190:204-209.
33. Tooth L, Ware R, Bain C, Purdie DM, Dobson A. Quality of reporting of observational longitudinal research. Am J Epidemiol 2005; 161:280-288.
34. Bogardus ST Jr., Concato J, Feinstein AR. Clinical epidemiological quality in molecular genetic research: The need for methodological standards. JAMA 1999; 281:1919-1926.
35. Verhalen RD. Guidelines for documentation of epidemiologic studies. Am J Epidemiol 1981; 114:609-613.
36. Rennie D. CONSORT revised - improving the reporting of randomized trials. JAMA 285:2006-2007.
37. Zwarenstein M, Treweek S, Gagnier JJ, Altman DG, Tunis S, Haynes B, Oxman AD, Moher D; CONSORT group; Pragmatic Trials in Healthcare (Practihc) group. Improving the reporting of pragmatic trials: An extension of the CONSORT statement. BMJ 2008; 337:1223-1226.
38. Manchikanti L, Hirsch JA, Smith HS. Evidence-based medicine, systematic reviews, and guidelines in interventional pain management: Part 2: Randomized controlled trials. Pain Physician 2008; 11:713-775.
39. Peipert JF, Phipps MG. Observational studies. Clin Obstet Gynecol 1998; 41:235-244.
40. Ioannidis JP, Lau J. Pooling research results. Jt Comm J Qual Improv 1999; 25:462-469.
41. Lipsett M, Campleman S. Occupational exposure to diesel exhaust and lung cancer: A metaanalysis. Am J Public Health 1999; 89:1009-1017.
42. West S, King V, Carey TS, Lohr KN, McKoy N, Sutton SF, Lux L. Systems to Rate the Strength of Scientific Evidence, Evidence Report, Technology Assessment No. 47. AHRQ Publication No. 02-E016. Rockville, MD: Agency for Healthcare Research and Quality, 2002. www.thecre.com/pdf/ ahrq-system-strength.pdf
43. Lijmer JG, Mol BW, Heisterkamp S, Bonsel GJ, Prins MH, van der Meulen JH, Bossuyt PM. Empirical evidence of design-related bias in studies of diagnostic tests. JAMA 1999; 282:1061-1066.
44. Reid MC, Lachs MS, Feinstein AR. Use of methodological standards in diagnostic test research. Getting better but still not good. JAMA 1995; 274:645-651.
45. Whiting P, Rutjes A, Reitsma J, Bossuyt P, Kleijnen J. The development of QUADAS: A tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews. BMC Med Res Methodol 2003; 3:25.
46. Bossuyt PM, Reitsma JB, Bruns DE, Gatsonis CA, Glasziou PP, Irwig LM, Lijmer JG, Moher D, Rennie D, de Vet HC; Standards for Reporting of Diagnostic Accuracy. Towards complete and accurate reporting of studies of diagnostic accuracy: The STARD initiative. Clin Chem 2003; 49:1-6.
47. Vickers A, Cassileth B, Ernst E, Fisher P, Goldman P, Jonas W, Kang SK, Lewith G, Schulz K, Silagy C. How should we research unconventional therapies? A panel report from the Conference on Complementary and Alternative Medicine Research Methodology, National Institutes of Health. Int J Technol Assess Health Care 1997; 13:111-121.
48. Mann CC. Can meta-analysis make policy? Science 1994; 266:960-962.
49. World Health Organization. International Clinical Trials Registry Platform (ICTRP). 2007. www.who.int/entity/ictrp/en/
50. Boswell MV, Trescot AM, Datta S, Schultz DM, Hansen HC, Abdi S, Sehgal N, Shah RV, Singh V, Benyamin RM, Patel VB, Buenaventura RM, Colson JD, Cordner HJ, Epter RS, Jasper JF, Dunbar EE, Atluri SL, Bowman RC, Deer TR, Swicegood JR, Staats PS, Smith HS, Burton AW, Kloth DS, Giordano J, Manchikanti L. Interventional techniques: Evidence-based practice guidelines in the management of chronic spinal pain. Pain Physician 2007; 10:7-111.
51. Manchikanti L, Pampati V, Rivera JJ, Beyer CD, Damron KS, Barnhill RC. Caudal epidural injections with Sarapin or steroids in chronic low back pain. Pain Physician 2001; 4:322-335.
52. Manchikanti L, Singh V, Rivera JJ, Pampati V, Beyer CD, Damron KS, Barnhill RC. Effectiveness of caudal epidural injections in discogram positive and negative chronic low back pain. Pain Physician 2002; 5:18-29.
53. Manchikanti L. Interventional pain management: Past, present, and future. The Prithvi Raj lecture: Presented at the 4th World Congress-World Institute of Pain, Budapest, 2007. Pain Pract 2007; 7:357-371.
54. Manchikanti L, Manchikanti KN, Manchukonda R, Pampati V, Cash KA. Evaluation of therapeutic thoracic medial branch block effectiveness in chronic thoracic pain: A prospective outcome study with minimum 1-year follow up. Pain Physician 2006; 9:97-105.
55. Manchikanti L, Manchikanti KN, Damron KS, Pampati V. Effectiveness of cervical medial branch blocks in chronic neck pain: A prospective outcome study. Pain Physician 2004; 7:195-201.
56. Trescot AM, Chopra P, Abdi S, Datta S, Schultz DM. Systematic review of effectiveness and complications of adhesiolysis in the management of chronic spinal pain: An update. Pain Physician 2007; 10:129-146.
57. Abdi S, Datta S, Trescot AM, Schultz DM, Adlaka R, Atluri SL, Smith HS, Manchikanti L. Epidural steroids in the management of chronic spinal pain: A systematic review. Pain Physician 2007; 10:185-212.
58. Boswell MV, Colson JD, Sehgal N, Dunbar EE, Epter R. A systematic review of therapeutic facet joint interventions in chronic spinal pain. Pain Physician 2007; 10:229-253.
59. Hansen HC, McKenzie-Brown AM, Cohen SP, Swicegood JR, Colson JD, Manchikanti L. Sacroiliac joint interventions: A systematic review. Pain Physician 2007; 10:165-184.
60. Barnsley L. Percutaneous radiofrequency neurotomy for chronic neck pain: Outcomes in a series of consecutive patients. Pain Med 2005; 6:282-286.
61. Sapir D, Gorup JM. Radiofrequency medial branch neurotomy in litigant and nonlitigant patients with cervical whiplash. Spine 2001; 26:E268-E273.
62. Manchikanti L, Singh V, Vilims BD, Hansen HC, Schultz DM, Kloth DS. Medial branch neurotomy in management of chronic spinal pain: Systematic review of the evidence. Pain Physician 2002; 5:405-418.
63. Dreyfuss P, Halbrook B, Pauza K, Joshi A, McLarty J, Bogduk N. Efficacy and validity of radiofrequency neurotomy for chronic lumbar zygapophysial joint pain. Spine 2000; 25:1270-1277.
64. Lutz GE, Vad VB, Wisneski RJ. Fluoroscopic transforaminal lumbar epidural steroids: An outcome study. Arch Phys Med Rehabil 1998; 79:1362-1366.
65. Buttermann GR. The effect of spinal steroid injections for degenerative disc disease. Spine J 2004; 4:495-505.
66. Buttermann GR. Treatment of lumbar disc herniation: Epidural steroid injection compared with discectomy. A prospective, randomized study. J Bone Joint Surg Am 2004; 86-A:670-679.
67. Botwin KP, Gruber RD, Bouchlas CG, Torres-Ramos FM, Sanelli JT, Freeman ED, Slaten WK, Rao S. Fluoroscopically guided lumbar transformational epidural steroid injections in degenerative lumbar stenosis: An outcome study. Am J Phys Med Rehabil 2002; 81:898-905.
68. Bush K, Hillier S. Outcome of cervical radiculopathy treated with periradicular/epidural corticosteroid injections: A prospective study with independent clinical review. Eur Spine J 1996; 5:319-325.
69. Gerdesmeyer L, Lampe R, Veihelmann A, Burgkart R, Gobel M, Gollwitzer H, Wagner K. Chronic radiculopathy. Use of minimally invasive percutaneous epidural neurolysis according to Racz. Der Schmerz 2005; 19:285-295.
70. Igarashi T, Hirabayashi Y, Seo N, Saitoh K, Fukuda H, Suzuki H. Lysis of adhesions and epidural injection of steroid/local anesthetic during epiduroscopy potentially alleviate low back and leg pain in elderly patients with lumbar spine stenosis. Br J Anaesth 2004; 93:181-187.
71. Geurts JW, Kallewaard JW, Richardson J, Groen. Targeted methylprednisolone acetate/hyaluronidase/clonidine injection after diagnostic epiduroscopy for chronic sciatica: A prospective, 1-year follow-up study. Reg Anesth Pain Med 2002; 27:343-352.
72. McLeod RS. Issues in surgical randomized controlled trials. World J Surg 1999; 23:1210-1214.
73. Solomon MJ, Laxamana A, Devore L, McLeod RS. Randomized controlled trials in surgery. Surgery 1994; 115:707-712.
74. Hardin WD Jr, Stylianos S, Lally KP. Evidence-based practice in pediatric surgery. J Pediatr Surg 1999; 34:908-912.
75. McCulloch P, Taylor I, Sasako M, Lovett B, Griffin D. Randomised trials in surgery: Problems and possible solutions. BMJ 2002; 324:1448-1451.
76. Manchikanti L, Cash KA, McManus CD, Pampati V, Smith HS. Preliminary results of randomized, equivalence trial of fluoroscopic caudal epidural injections in managing chronic low back pain: Part 1. Discogenic pain without disc herniation or radiculitis. Pain Physician 2008; 11:785-800.
77. Manchikanti L, Singh V, Cash KA, Pampati V, Damron KS, Boswell MV. Preliminary results of randomized, equivalence trial of fluoroscopic caudal epidural injections in managing chronic low back pain: Part 2. Disc herniation and radiculitis. Pain Physician 2008; 11:801-815.
78. Manchikanti L, Singh V, Cash KA, Pampati V, Datta S. Preliminary results of randomized, equivalence trial of fluoroscopic caudal epidural injections in managing chronic low back pain: Part 3. Post surgery syndrome. Pain Physician 2008; 11:817-831.
79. Manchikanti L, Cash KA, McManus CD, Pampati V, Abdi S. Preliminary results of randomized, equivalence trial of fluoroscopic caudal epidural injections in managing chronic low back pain: Part 4. Spinal stenosis. Pain Physician 2008; 11:833-848.
80. Manchikanti L, Singh V, Falco FJE, Cash KA, Pampati V. Lumbar facet joint nerve blocks in managing chronic facet joint pain: One-year follow-up of a randomized, double-blind controlled trial: Clinical Trial NCT00355914. Pain Physician 2008; 11:121-132.
81. Manchikanti L, Singh V, Falco FJ, Cash KM, Fellows B. Cervical medial branch blocks for chronic cervical facet joint pain: A randomized, double-blind, controlled trial with 1-year follow-up. Spine 2008; 33:1813-1820.
82. Manchikanti L, Singh V, Falco FJ, Cash KM, Pampati V. Effectiveness of thoracic medial branch blocks in managing chronic pain: A preliminary report of a randomized, double-blind controlled trial: Clinical Trial NCT00355706. Pain Physician 2008; 11:491-504.
83. Manchikanti L, Damron KS, Cash KA, Manchukonda R, Pampati V. Therapeutic medial branch blocks in managing chronic neck pain: A preliminary report of a randomized, double-blind, controlled trial: Clinical Trial NCT0033272. Pain Physician 2006; 9:333-346.
84. Manchikanti L, Manchikanti K, Manchukonda R, Cash KA, Damron KS, Pampati V, McManus CD. Evaluation of lumbar facet joint nerve blocks in the management of chronic low back pain: A preliminary report of a randomized, double-blind controlled trial. Clinical Trial NCT000355914. Pain Physician 2007; 10:425-440.
85. Levin JH. Prospective, double-blind, randomized placebo-controlled trials in interventional spine: What the highest quality literature tells us. Spine J 2008; Sep 11 [Epub ahead of print].
86. Antman K, Ayash L, Elias A, Wheeler C, Hunt M, Eder JP, Teicher BA, Critchlow J, Bibbo J, Schnipper LE, Frei III E. A phase II study of high-dose cyclophosphamide, thiotepa, and carboplatin with autologous marrow support in women with measurable advanced breast cancer responding to standard-dose therapy. J Clin Oncol 1992; 10:102-110.
87. Farquhar C, Marjoribanks J, Basser R, Hetrick S, Lethaby A. High dose chemotherapy and autologous bone marrow or stem cell transplantation versus conventional chemotherapy for women with metastatic breast cancer. Cochrane Database Syst Rev 2005; CD003142.
88. Peters WP, Shpall EJ, Jones RB, Olsen GA, Bast RC, Gockerman JP, Moore JO. High-dose combination alkylating agents with bone marrow support as initial treatment for metastatic breast cancer. J Clin Oncol 1988; 6:1368-1376.
89. The EC/IC Bypass Study Group. Failure of extracranial-intracranial arterial bypass to reduce the risk of ischemic stroke. Results of an international randomized trial. N Engl J Med 1985; 313:1191-1200.
90. Weinstein PR, Rodriguez Y, Baena R, Chater NL. Results of extracranial-intracranial arterial bypass for intracranial internal carotid artery stenosis: Review of 105 cases. Neurosurgery 1984; 15:787-794.
91. Guyatt G, Drummond R. Part 2. The Basics: Using and Teaching the Principles of Evidence-Based Medicine. 2B1. Therapy and validity. In: Users' Guides to the Medical Literature: A Manual for Evidence-Based Clinical Practice. American Medical Association, Chicago, 2002, pp 247-308.
92. Solomon MJ, McLeod RS. Should we be performing more randomized controlled trials evaluating surgical operations? Surgery 995; 118:459-467.
93. Pawlik TM, Abdalla EK, Barnett CC, Ahmad SA, Cleary KR, Vauthey JN, Lee JE, Evans DB, Pisters PW. Feasibility of a randomized trial of extended lymphadenectomy for pancreatic cancer. Arch Surg 2005; 140:584-589.
94. Balasubramanian SP, Wiener M, Alshameeri Z, Tiruvoipati R, Elbourne D, Reed MW. Standards of reporting of randomized controlled trials in general surgery: Can we do better? Ann Surg 2006; 244:663-667.
95. Jacquier I, Boutron I, Moher D, Roy C, Ravaud P. The reporting of randomized clinical trials using a surgical intervention is in need of immediate improvement: A systematic review. Ann Surg 2006; 244:677-683.
96. International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use. ICH Harmonised Tripartite Guideline. Choice of Control Group and Related Issues in Clinical Trials E10. July 20, 2000.
97. Kao LS, Tyson JE, Blakely ML, Lally KP. Clinical research methodology I: Introduction to randomized trials. J Am Coll Surg 2008; 206:361-369.
98. Braunholtz DA, Edwards SJ, Lilford RJ. Are randomized clinical trials good for us (in the short term)? Evidence for a "trial effect." J Clin Epidemiol 2001; 54:217-224.
99. Weijer C, Freedman B, Fuks A, Robbins J, Shapiro S, Skrutkowska M. What difference does it make to be treated in a clinical trial? A pilot study. Clin Invest Med 1996; 19:179-183.
100. Manchikanti L, Pampati V, Damron KS. The role of placebo and nocebo effects of perioperative administration of sedatives and opioids in interventional pain management. Pain Physician 2005; 8:349-355.
101. Hrobjartsson A, Gotzsche PC. Is the placebo powerless? An analysis of clinical trials comparing placebo with no treatment. N Engl J Med 2001; 344:1594-1602.
102. Hrobjartsson A, Gotzsche PC. Is the placebo powerless? Update of a systematic review with 52 new randomized trials comparing placebo with no treatment. J Intern Med 2004; 256:91-100.
103. Koshi EB, Short CA. Placebo theory and its implications for research and clinical practice: A review of the recent literature. Pain Pract 2007; 7:4-20.
104. Carette S, Leclaire R, Marcoux S, Morin F, Blaise G, St. Pierre A, Truchon R, Parent F, Levesque J, Bergeron V, Montminy P, Blanchette C. Epidural corticosteroid injections for sciatica due to herniated nucleus pulposus. N Engl J Med 1997; 336:1634-1640.
105. Carette S, Marcoux S, Truchon R, Grondin C, Gagnon J, Allard Y, Latulippe M. A controlled trial of corticosteroid injections into facet joints for chronic low back pain. N Engl J Med 1991; 325:1002-1007.
106. Karppinen J, Malmivaara A, Kurunlahti M, Kyllonen E, Pienimaki T, Nieminen P, Ohinmaa A, Tervonen O, Vanharanta H. Periradicular infiltration for sciatica. A randomized controlled trial. Spine 2001; 26:1059-1067.
107. Lord SM, Barnsley L, Wallis BJ, McDonald GJ, Bogduk N. Percutaneous radiofrequency neurotomy for chronic cervical zygapophyseal-joint pain. N Engl J Med 1996; 5:1721-1726.
108. Riew KD, Park JB, Cho YS, Gilula L, Patel A, Lenke LG, Bridwell KH. Nerve root blocks in the treatment of lumbar radicular pain. A minimum five-year followup. J Bone Joint Surg Am 2006; 88:1722-1725.
109. Karppinen J, Ohinmaa A, Malmivaara A, Kurunlahti M, Kyllonen E, Pienimaki T, Nieminen P, Tervonen O, Vanharanta H. Cost effectiveness of periradicular infiltration for sciatica. Spine 2001; 26:2587-2595.
110. Manchikanti L, Pampati V, Fellows B, Bakhit CE. The diagnostic validity and therapeutic value of lumbar facet joint nerve blocks with or without adjuvant agents. Curr Rev Pain 2000; 4:337-344.
111. Cuckler JM, Bernini PA, Wiesel SW, Booth RE Jr, Rothman RH, Pickens GT. The use of epidural steroid in the treatment of radicular pain. J Bone Joint Surg 1985; 67:63-66.
112. Manchikanti KN, Pampati V, Damron KS, McManus CD. A double-blind, controlled evaluation of the value of Sarapin in neural blockade. Pain Physician 2004; 7:59-62.
113. MacPherson H. Pragmatic clinical trials. Complement Ther Med 2004; 12:136-140.
114. Sacks H, Chalmers TC, Smith H Jr. Randomized versus historical controls for clinical trials. Am J Med 1982; 72:233-240.
115. Shikata S, Nakayama T, Noguchi Y, Taji Y, Yamagishi H. Comparison of effects in randomized controlled trials with observational studies in digestive surgery. Ann Surg 2006; 244:668-676.
116. Groenwold RH, Van Deursen AM, Hoes AW, Hak E. Poor quality of reporting confounding bias in observational intervention studies: A systematic review. Ann Epidemiol 2008; 18:746-751.
117. Hartz A, Bentler S, Charlton M, Lanska D, Butani Y, Soomro GM, Benson K. Assessing observational studies of medical treatments. Emerg Themes Epidemiol 2005; 2:8.
118. Kane RL. Approaching the outcomes question. In: Kane RL (ed). Understanding Health Care Outcomes Research. Aspen Publications, Gaithersburg, 1997, pp 1-15.
119. Manchikanti L, Pampati V. Research designs in interventional pain management: Is randomization superior, desirable or essential? Pain Physician 2002; 5:275-284.
120. Carragee EJ, Hurwitz EL, Cheng I, Carroll LJ, Nordin M, Guzman J, Peloso P, Holm LW, Côté P, Hogg-Johnson S, van der Velde G, Cassidy JD, Haldeman S, Bone and Joint Decade 2000-2010 Task Force on Neck Pain and Its Associated Disorders. Treatment of neck pain: Injections and surgical interventions: Results of the Bone and Joint Decade 2000-2010 Task Force on Neck Pain and Its Associated Disorders. Spine 2008; 33:S153-S169.
121. Benson K, Hartz AJ. A comparison of observational studies and randomized, controlled trials. N Engl J Med 2000; 342:1878-1886.
122. Hartz A, Benson K, Glaser J, Bentler S, Bhandari M. Assessing observational studies of spinal fusion and chemonucleolysis. Spine 2003; 28:2268-2275.
123. Concato J, Shah N, Horwitz RI. Randomized, controlled trials, observational studies, and the hierarchy of research designs. N Engl J Med 2000; 342:1887-1892.
124. Shrier I, Boivin JF, Steele RJ, Platt RW, Furlan A, Kakuma R, Brophy J, Rossignol M. Should meta-analyses of interventions include observational studies in addition to randomized controlled trials? A critical examination of underlying principles. Am J Epidemiol 2007; 166:1203-1209.
125. American College of Occupational and Environmental Medicine. Low Back Disorders Chapter. In: Occupational Medicine Practice Guidelines: Evaluation and Management of Common Health Problems and Functional Recovery of Workers, Second Edition. American College of Occupational and Environmental Medicine, Elk Grove Village, 2007.
126. American College of Occupational and Environmental Medicine. Chronic Pain Chapter (revised 2008). In: Occupational Medicine Practice Guidelines: Evaluation and Management of Common Health Problems and Functional Recovery of Workers, Second Edition. American College of Occupational and Environmental Medicine, Elk Grove Village, Epublished August 14, 2008.
127. Manchikanti L, Singh V, Derby R, Helm S, Trescot AM, Staats PS, Prager JP, Hirsch JA. Review of occupational medicine practice guidelines for interventional pain management and potential implications. Pain Physician 2008; 11:271-289.
128. Manchikanti L, Singh V, Helm S, Trescot AM, Hirsch JA. A critical appraisal of 2007 American College of Occupational and Environmental Medicine (ACOEM) practice guidelines for interventional pain management: An independent review utilizing AGREE, AMA, IOM, and other criteria. Pain Physician 2008; 11:291-310.
129. Letter to Robert K. McLellan, MD, President of the American College of Occupational & Environmental Medicine (ACOEM) from the Honorable Bart Stupak and Ed Whitfield, U.S. House of Representatives, January 25, 2008.
130. Chou R. Using evidence in pain practice: Part I: Assessing quality of systematic reviews and clinical practice guidelines. Pain Med 2008; 9:518-530.
131. Chou R. Using evidence in pain practice: Part II: Interpreting and applying systematic reviews and clinical practice guidelines. Pain Med 2008; 9:531-541.
132. Koes BW, Scholten RJ, Mens JM, Bouter LM. Efficacy of epidural steroid injections for low-back pain and sciatica: A systematic review of randomized clinical trials. Pain 1995; 63:279-288.
133. Sanders SH, Harden RN, Benson SE, Vicente PJ. Clinical practice guidelines for chronic non-malignant pain syndrome patients II: An evidence-based approach. J Back Musc Rehabil 1999; 13:47-58.
134. van Tulder MWV, Koes BW, Bouter LM. Conservative treatment of acute and chronic nonspecific low back pain. A systematic review of randomized controlled trials of the most common interventions. Spine 1997; 22:2128-2156.
135. Nelemans PJ, Debie RA, DeVet HC, Sturmans F. Injection therapy for subacute and chronic benign low back pain. Spine 2001; 26:501-515.
136. Geurts JW, van Wijk RM, Stolker RJ, Groen GJ. Efficacy of radiofrequency procedures for the treatment of spinal pain: A systematic review of randomized clinical trials. Reg Anesth Pain Med 2001; 26:394-400.
137. Resnick DK, Choudhri TF, Dailey AT, Groff MW, Khoo L, Matz PG, Mummaneni P, Watters WC 3rd, Wang J, Walters BC, Hadley MN; American Association of Neurological Surgeons/Congress of Neurological Surgeons. Guidelines for the performance of fusion procedures for degenerative disease of the lumbar spine. Part 13: Injection therapies, lowback pain, and lumbar fusion. J Neurosurg Spine 2005; 2:707-715.
138. Niemisto L, Kalso E, Malmivaara A, Seitsalo S, Hurri H. Cochrane Collaboration Back Review Group. Radiofrequency denervation for neck and back pain: A systematic review within the framework of the Cochrane collaboration back review group. Spine 2003, 28:1877-1888.
139. Manchikanti L, Singh V, Derby R, Schultz DM, Benyamin RM, Prager JP, Hirsch JA. Reassessment of evidence synthesis of occupational medicine practice guidelines for interventional pain management. Pain Physician 2008; 11:393-482.
140. Bigos SJ, Boyer OR, Braen GR, Brown K, Deyo R. Acute Low Back Problems in Adults. Clinical Practice Guideline Number 4. AHCPR Publication No. 95-0642. Agency for Health Care Policy and Research, Public Health Service, US Department of Health and Human Services, Rockville, December 1994.
141. Airaksinen O, Brox JI, Cedraschi C, Hildebrandt J, Klaber-Moffett J, Kovacs F, Mannion AF, Reis S, Staal JB, Ursin H, Zanoli G. Chapter 4: European guidelines for the management of chronic nonspecific low back pain. Eur Spine J 2006; 15: S192-S300.
142. Armon C, Argoff CE, Samuels J, Backonja MM; Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Assessment: Use of epidural steroid injections to treat radicular lumbosacral pain: Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 2007; 68:723-729.
143. Staal JB, de Bie R, de Vet HC, Hildebrandt J, Nelemans P. Injection therapy for subacute and chronic low-back pain. Cochrane Database Syst Rev 2008; 3: CD001824.
144. Peloso PMJ, Gross A, Haines T, Trinh K, Goldsmith CH, Burnie SJ; Cervical Overview Group. Medicinal and injection therapies for mechanical neck disorders. Cochrane Database Syst Rev 2007; 3:CD000319.
145. Manchikanti L, Singh V, Helm II S, Hirsch JA. Evidence-based medicine, systematic reviews, and guidelines in interventional pain management: Part 3: Systematic reviews and meta-analysis of randomized trials. Pain Physician 2009; 12:35-72.
146. Manchikanti L, Boswell MV, Giordano J. Evidence-based interventional pain management: Principles, problems, potential, and applications. Pain Physician 2007; 10:329-356.
147. Manchikanti L. Evidence-based medicine, systematic reviews, and guidelines in interventional pain management: Part 1: Introduction and general considerations. Pain Physician 2008; 11:161-186.
148. Manchikanti L, Heavner J, Racz GB, Mekhail NA, Schultz DM, Hansen HC, Singh V. Methods for evidence synthesis in interventional pain management. Pain Physician 2003; 6:89-111.
149. Cho MK, Bero LA. Instruments for assessing the quality of drug studies published in the medical literature. JAMA 1994; 272:101-104.
150. Goodman SN, Berlin J, Fletcher SW, Fletcher RH. Manuscript quality before and after peer review and editing at Annals of Internal Medicine. Ann Intern Med 1994; 121:11-21.
151. Downs SH, Black N. The feasibility of creating a checklist for the assessment of the methodological quality both of randomized and non-randomised studies of health care interventions. J Epidemiol Community Health 1998; 52:377-384.
152. Corrao G, Bagnardi V, Zambon A, Arico S. Exploring the dose-response relationship between alcohol consumption and the risk of several alcohol-related conditions: A metaanalysis. Addiction 1999; 94:1551-1573.
153. Khan KS, Ter Riet G, Popay J, Nixon J, Kleijnen J. Undertaking systematic reviews of research effectiveness. CRD's guidance for those carrying out or commissioning reviews. CRD Report number 4 (2nd edn). 2001. The University of York Centre for Reviews and Dissemination.
154. New Zealand Guidelines Group. Tools for Guideline Development & Evaluation. www.nzgg.org.nz/
155. Harbour R, Miller J. A new system for grading recommendations in evidence based guidelines. BMJ 2001; 323:334-336.
156. Reisch JS, Tyson JE, Mize SG. Aid to the evaluation of therapeutic studies. Pediatrics 1989; 84:815-827.
157. Spitzer WO, Lawrence V, Dales R, Hill G, Archer MC, Clark P, Abenhaim L, Hardy J, Sampalis J, Pinfold SP. Links between passive smoking and disease: A best-evidence synthesis. A report of the Working Group on Passive Smoking. Clin Invest Med 1990; 13:17-42.
158. National Health and Medical Research Council (NHMRC). How to Review the Evidence: Systematic Identification and Review of the Scientific Literature. NHMRC, Canberra, Australia, 2000.
159. Zaza S, Wright-De Agüero LK, Briss PA, Truman BI, Hopkins DP, Hennessy MH, Sosin DM, Anderson L, Carande-Kulis VG, Teutsch SM, Pappaioanou M. Data collection instrument and procedure for systematic reviews in the Guide to Community Preventive Services. Task Force on Community Preventive Services. Am J Prev Med 2000; 18:44-74.
160. Ariens GA, van Mechelen W, Bongers PM, Bouter LM, van der Wal G. Physical risk factors for neck pain. Scand J Work Environ Health 2000; 26:7-19.
161. Lohr KN, Carey TS. Assessing "best evidence": Issues in grading the quality of studies for systematic reviews. Jt Comm J Qual Improv 1999; 25:470-479.
162. Carruthers SG, Larochelle P, Haynes RB, Petrasovits A, Schiffrin EL. Report of the Canadian Hypertension Society Consensus Conference: 1. Introduction. CMAJ 1993; 149:289-293.
163. Laupacis A, Wells G, Richardson WS, Tugwell P. Users' guides to the medical literature. V. How to use an article about prognosis. Evidence-Based Medicine Working Group. JAMA 1994; 272:234-237.
164. Levine M, Walter S, Lee H, Haines T, Holbrook A, Moyer V. Users' guides to the medical literature. IV. How to use an article about harm. Evidence-Based Medicine Working Group. JAMA 1994; 271:1615-1619.
165. Angelillo IF, Villari P. Residential exposure to electromagnetic fields and childhood leukaemia: A meta-analysis. Bull World Health Organ 1999; 77:906-915.
166. Chestnut RM, Carney N, Maynard H, Patterson P, Mann NC, Helfand M. Rehabilitation for Traumatic Brain Injury. Evidence Report/Technology Assessment No. 2. Rockville, Md.: Agency for Health Care Policy and Research. AHCPR Publication No. 99-E006; 1999.
167. Vickrey BG, Shekelle P, Morton S, Clark K, Pathak M, Kamberg C. Prevention and Management of Urinary Tract Infections in Paralyzed Persons. Evidence Report/Technology Assessment No. 6. Rockville, Md.: Agency for Health Care Policy and Research. AHCPR Publication No. 99-E008; 1999.
168. Atluri S, Datta S, Falco FJE, Lee M. Systematic review of diagnostic utility and therapeutic effectiveness of thoracic facet joint interventions. Pain Physician 2008; 11:611-629.
169. Conn A, Buenaventura R, Datta S. Abdi S, Diwan S. Systematic review of caudal epidural injections in the management of chronic low back pain. Pain Physician 2009; 12:109-135.
170. Parr AT, Diwan S, Abdi S. Lumbar interlaminar epidural injections in managing chronic low back and lower extremity pain: A systematic review. Pain Physician 2009; 12:163-188.
171. Benyamin R, Singh V, Parr AT, Conn A, Diwan S, Abdi S. Systematic review of the effectiveness of cervical epidurals in the management of chronic neck pain. Pain Physician 2009; 12:137-157.
172. Helm S, Hayek S, Benyamin R, Manchikanti L. Systematic review of effectiveness of thermal annular procedures in treating discogenic low back pain. Pain Physician 2009; 12:207-232.
173. Sanderson S, Tatt ID, Higgins JP. Tools for assessing quality and susceptibility to bias in observational studies in epidemiology: A systematic review and annotated bibliography. Int J Epidemiol 2007; 36:666-676.
174. Avis M. Reading research critically. II. An introduction to appraisal: Assessing the evidence. J Clin Nurs 1994; 3:271-277.
175. DuRant RH. Checklist for the evaluation of research articles. J Adolesc Health 1994; 15:4-8.
176. Elwood M. Forward projection - using critical appraisal in the design of studies. Int J Epidemiol 2002; 31:1071-1073.
177. Hadorn DC, Baker D, Hodges JS, Hicks N. Rating the quality of evidence for clinical practice guidelines. J Clin Epidemiol 1996; 49:749-754.
178. Zola P, Volpe T, Castelli G, Sismondi P, Nicolucci A, Parazzini F, Liberati A. Is the published literature a reliable guide for deciding between alternative treatments for patients with early cervical cancer? Int J Radiat Oncol Biol Phys 1989; 16:785-797.
179. Borghouts JA, Koes BW, Bouter LM. The clinical course and prognostic factors of non-specific neck pain: A systematic review. Pain 1998; 77:1-13.
180. Loney PL, Chambers LW, Bennett KJ, Roberts JG, Stratford PW. Critical appraisal of the health research literature: Prevalence or incidence of a health problem. Chronic Dis Canada 2000; 19:170-177.
181. Littenberg B, Weinstein LP, McCarren M, Mead T, Swiontkowski MF, Rudicel SA, Heck D. Closed fractures of the tibial shaft. A meta-analysis of three methods of treatment. J Bone Joint Surg Am 1998; 80:174-183.
182. Macfarlane TV, Glenny AM, Worthington HV. Systematic review of populationbased epidemiological studies of orofacial pain. J Dent 2001; 29:451-467.
183. Margetts BM, Thompson RL, Key T, Duffy S, Nelson M, Bingham S, Wiseman M. Development of a scoring system to judge the scientific quality of information from case-control and cohort studies of nutrition and disease. Nutr Cancer 1995; 24:231-239.
184. Rangel SJ, Kelsey J, Colby CE, Anderson J, Moss RL. Development of a quality assessment scale for retrospective clinical studies in pediatric surgery. J Pediatr Surg 2003; 38:390-396.
185. van der Windt DAWM, Thomas E, Pope DP, de Winter AF, Macfarlane GJ, Bouter LM, Silman AJ. Occupational risk factors for shoulder pain: A systematic review. Occup Environ Med 2000; 57:433-442.
186. Cowley DE. Prostheses for primary total hip replacement. A critical appraisal of the literature. Int J Technol Assess Health Care 1995; 11:770-778.
187. Fowkes FG, Fulton PM. Critical appraisal of published research: introductory guidelines. BMJ 1991; 302:1136-1140.
188. Gyorkos TW, Tannenbaum TN, Abrahamowicz M, Oxman AD, Scott EA, Millson ME, Rasooly I, Frank JW, Riben PD, Mathias RG. An approach to the development of practice guidelines for community health interventions. Can J Public Health 1994; 85:S8-S13.
189. Steinberg EP, Eknoyan G, Levin NW, Eschbach JW, Golper TA, Owen WF, Schwab S. Methods used to evaluate the quality of evidence underlying the National Kidney Foundation-Dialysis Outcomes Quality Initiative Clinical Practice Guidelines: Description, findings, and Implications. Am J Kidney Dis 2000; 36:1-11.
190. Mihailovic A, Bell CM, Urbach DR. Users' guide to the surgical literature. Case-control studies in surgical journals. Can J Surg 2005 48:148-151.
191. Feinstein AR, Horwitz RI. Problems in the "evidence" of "evidence-based medicine." Am J Med 1997; 103:529-535.
192. Bradley C. Designing medical and educational intervention studies: A review of some alternatives to conventional randomized controlled trials. Diabetes Care 1993; 16:509-519.
193. Torgerson D, Klaber-Moffett J, Russell I. Patient preferences in randomized trials: Threat or opportunity. J Health Serv Res Policy 1996; 1:194-197.
194. Browner WS. Methods. In: Publishing and Presenting Clinical Research. Lippincott Williams & Wilkins, Philadelphia, 2006, pp 27-44.
195. Riegelman RK. Types of studies and the M.A.A.R.I.E. Framework. In: Studying a Study & Testing a Test. How to Read the Medical Evidence, 5th edition. Lippincott Williams & Wilkins, Philadelphia, 2005, pp 7-15.
196. Including non-randomized studies. In: Higgins JPT, Green S (eds). Cochrane Handbook for Systematic Reviews of Interventions. Version 5.0.1 Cochrane Collaboration, Oxford, 2008.
197. Ioannidis JP. Effect of formal statistical significance on the credibility of observational associations. Am J Epidemiol 2008; 168:374-383.
198. Altman DG, De Stavola BL, Love SB, Stepniewska KA. Review of survival analyses published in cancer journals. Br J Cancer 1995; 72:511-518.
199. Phillips MR, Yang G, Zhang Y, Wang L, Ji H, Zhou M. Risk factors for suicide in China: A national case-control psychological autopsy study. Lancet 2002; 360:1728-1736.
200. Pasquale LR, Kang JH, Manson JE, Willett WC, Rosner BA, Hankinson SE. Prospective study of type 2 diabetes mellitus and risk of primary open-angle glaucoma in women. Ophthalmology 2006; 113:1081-1086.
201. Craig SL, Feinstein AR. Antecedent therapy versus detection bias as causes of neoplastic multimorbidity. Am J Clin Oncol 1999; 22:51-56.
202. Rogler LH, Mroczek DK, Fellows M, Loftus ST. The neglect of response bias in mental health research. J Nerv Ment Dis 2001; 189:182-187.
203. Morton LM, Cahill J, Hartge P. Reporting participation in epidemiologic studies: A survey of practice. Am J Epidemiol 2006; 163:197-203.
204. Veldhuyzen van Zanten SJ, Cleary C, Talley NJ, Peterson TC, Nyren O, Bradley LA, Verlinden M, Tytgat GN. Drug treatment of functional dyspepsia: A systematic analysis of trial methodology with recommendations for design of future trials. Am J Gastroenterol 1996; 91:660-673.
205. Adetugbo K, Williams H. How well are randomized controlled trials reported in the dermatology literature? Arch Dermatol 2000; 136:381-385.
206. Moher D, Jones A, Lepage L, CONSORT Group (Consolidated Standards for Reporting of Trials). Use of the CONSORT statement and quality of reports of randomized trials: A comparative before-and-after evaluation. JAMA 2001; 285:1992-1995.
207. Plint AC, Moher D, Morrison A, Schulz K, Altman DG, Hill C, Gaboury I. Does the CONSORT checklist improve the quality of reports of randomized controlled trials? A systematic review. Med J Aust 2006; 185:263-267.
208. Hopewell S, Altman DG, Moher D, Schulz KF. Endorsement of the CONSORT Statement by high impact factor medical journals: A survey of journal editors and journal "Instructions to Authors." Trials 2008; 9:20.
209. Prady SL, Richmond SJ, Morton VM, MacPherson H. A systematic evaluation of the impact of STRICTA and CONSORT recommendations on quality of reporting for acupuncture trials. PLoS ONE 2008; 3:e1577.
210. Vandenbroucke JP. Prospective or retrospective: What's in a name? BMJ 1991; 302:249-250.
211. Last JM. A Dictionary of Epidemiology, 4th Ed. Oxford University Press, New York, 2000.
212. Miettinen OS. Theoretical Epidemiology: Principles of Occurrence Research in Medicine. John Wiley & Sons, New York, 1985.
213. Rothman KJ, Greenland S. Types of Epidemiologic Studies. In: Rothman KJ, Greenland S (eds). Modern Epidemiology, 2nd ed. Lippincott Williams & Wilkins, Philadelphia, 1998, pp 74-75.
214. MacMahon B, Trichopoulos D. Epidemiology, Principles and Methods, 2nd ed. Little Brown and Company, Boston, 1996.
215. Lilienfeld AM. Foundations of Epidemiology. Oxford University Press, New York, 1976.
216. Clarke M, Oxman AD, editors. Cochrane Reviewers Handbook 4.1.4 [updated October 2001]. In: The Cochrane Library, Issue 4, 2001. Oxford: Update Software. Updated quarterly.
217. Green SB, Byar DP. Using observational data from registries to compare treatments: The fallacy of omnimetrics. Stat Med 1984; 3:361-373.
218. Salas M, Hofman A, Stricker BH. Confounding by indication: An example of variation in the use of epidemiologic terminology. Am J Epidemiol 1999; 149:981-983.
219. Horwitz RI, Feinstein AR. The application of therapeutic trial principles to improve the design of epidemiologic research. J Chron Dis 1981; 34:575-583.
220. Horwitz RI, Viscoli CM, Clemens JD, Sadock RT. Developing improved observational methods for evaluating therapeutic effectiveness. Am J Med 1990; 89:630-638.
221. Costanza MC. Matching. Prev Med 1995; 24:425-433.
222. Walker M, Whincup PH, Shaper AG. The British Regional Heart Study 1975-2004. Int J Epidemiol 2004; 33:1185-1192.
223. Wieland S, Dickersin K. Selective exposure reporting and Medline indexing limited the search sensitivity for observational studies of the adverse effects of oral contraceptives. J Clin Epidemiol 2005; 58:560-567.
224. Mann CJ. Observational research methods. Research design II: Cohort, cross sectional, and case-control studies. Emerg Med J 2003; 20:54-60.
225. Setia MS. Observational studies: How to go about them? Indian J Dermatol Venereol Leprol 2008; 74:288-291.
226. Lerner DJ, Kannel WB. Patterns of coronary heart disease morbidity and mortality in the sexes: A 26 year follow-up of the Framingham population. Am Heart J 1986; 111:383-390.
227. Doll R, Peto H. Mortality in relation to smoking. 40 years observation on female British doctors. BMJ 1989;208:967-973.
228. Alberman ED, Butler NR, Sheridan MD. Visual acuity of a national sample (1958 cohort) at 7 years. Dev Med Child Neurol 1971;13:9-14.
229. Smith GD, Hart C, Blane D, Hole D. Adverse socioeconomic conditions in childhood and cause specific mortality: Prospective observational study. BMJ 1998; 316:1631-1635.
230. Goyder EC, Goodacre SW, Botha JL, Bodiwala GG. How do individuals with diabetes use the accident and emergency department? J Accid Emerg Med 1997; 14:371-374.
231. Karjalainen J, Kujala U, Kaprio J, Sarna S, Viitasalo M. Lone atrial fibrillation in vigorously exercising middle aged men: case-control study. BMJ 1998; 316:1784-1785.
232. Turk DC, Melzack R. The measurement of pain and the assessment of people experiencing pain. In: Turk DC, Melzack R (eds). Handbook of Pain Assessment. 2nd ed. Guilford, New York, 2001, pp 13-14.
233. Ware JE, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992; 30:473-483.
234. Fairbank JC, Pynsent PB. The Oswestry Disability Index. Spine 2000; 25:2940-2952.
235. Roland M, Morris R. A study of the natural history of low back pain. Part 1: Development of a reliable and sensitive measure of disability in low-back pain. Spine 1983; 8:141-144.
236. Vernon H, Mior S. The Neck Disability Index: A study of reliability and validity. J Manipulative Physiol Ther 1991; 14:409-415.
237. Pietrobon R, Coeytaux RR, Carey TS, Richardson WJ, DeVellis RF. Standard scales for measurement of functional outcome for cervical pain or dysfunction. Spine 2002; 27:515-522.
238. Melzack R. The McGill Pain Questionnaire: Major properties and scoring methods. Pain 1975; 1:277-299.
239. Kuenstner S, Langelotz C, Budach V, Possinger K, Krause B, Sezer O. The comparability of quality of life scores: A multitrait multimethod analysis of the EORTC QOL-C30, SF-36 and FLIC questionnaires. Eur J Cancer 2002; 38:339-348.
240. Measuring and reporting pain outcomes in randomized controlled trials. Blue Cross Blue Shield Association. Technology Evaluation Center. Assessment Program. Volume 21, No. 11, October 2006.
241. Jensen MP, Karoly P. Self-report scales and procedures for assessing pain in adults. In: Turk DC, Melzack R (eds). Handbook of Pain Assessment, 2nd Edition. Guilford Press, New York, 2001, pp 15-34.
242. Turk DC. Statistical significance and clinical significance are not synonyms! Clin J Pain 2000; 16:185-187.
243. Farrar JT, Young JP Jr, LaMoreaux L, Werth JL, Poole RM. Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale. Pain 2001; 94:149-158.
244. Middel B, Stewart R, Bouma J, van Sonderen E, van den Heuvel W. How to validate clinically important change in health-related functional status. Is the magnitude of the effect size consistently related to magnitude of change as indicated by a global question rating? J Eval Clin Pract 2001; 7:399-410.
245. Wyrwich K, Nienaber N, Tierney W, Wolinsky F. Linking clinical relevance and statistical significance in evaluating intra-individual changes in health-related quality of life. Med Care 1999; 37:469-478.
246. Turk DC. Clinical effectiveness and cost-effectiveness of treatments for patients with chronic pain. Clin J Pain 2002; 18:355-365.
247. Stratford PW, Binkley JM, Riddle DL, Guyatt GH. Sensitivity to change of the Roland-Morris Back Pain Questionnaire: Part 1. Phys Ther 1998; 78:1186-1196.
248. Jaeschke R, Singer J, Guyatt GH. Measurement of health status. Ascertaining the minimal clinically important difference. Control Clin Trials 1989; 10:407-415.
249. van der Roer N, Ostelo RW, Bekkering GE, van Tulder MW, de Vet HC. Minimal clinically important change for pain intensity, functional status, and general health status in patients with nonspecific low back pain. Spine 2006; 31:578-582.
250. Goodman SN. Toward evidence-based medical statistics. 1: The P value fallacy. Ann Intern Med 1999; 130:995-1004.
251. Tannock IF. False-positive results in clinical trials: Multiple significance tests and the problem of unreported comparisons. J Natl Cancer Inst 1996; 88:206-207.
252. Altman DG, Bland JM. Absence of evidence is not evidence of absence. BMJ 1995; 311:485.
253. Moher D, Dulberg CS, Wells GA. Statistical power, sample size, and their reporting in randomized controlled trials. JAMA 1994; 272:122-124.
254. Freiman JA, Chalmers TC, Smith H Jr, Kuebler RR. The importance of beta, the type II error and sample size in the design and interpretation of the randomized control trial. Survey of 71 "negative" trials. N Engl J Med 1978; 299:690-694.
255. Scott PA, Kingsley GH, Smith CM, Choy EH, Scott DL. Non-steroidal anti-inflammatory drugs and myocardial infarctions: Comparative systematic review of evidence from observational studies and randomised controlled trials. Ann Rheum Dis 2007; 66:1296-1304.
256. Eng J. Sample size estimation: How many individuals should be studied? Radiology 2003; 227:309-313.
257. Woodward M. Formulas for sample-size, power and minimum detectable relative risk in medical studies. Statistician 1992; 41:185-196.
258. Browner WS, Newman TB, Cummings SR, Hulley SB. Estimating sample size and power. In: Hulley SB, Cummings SR, Browner WS, Grady D, Hearst N, Newman TB (eds). Designing Clinical Research: An Epidemiologic Approach, 2nd ed. Lippincott, Williams & Wilkins, Philadelphia, 2001, pp 65-84.
259. Altman DG, Gore SM, Gardner MJ, Pocock SJ. Statistical guidelines for contributors to medical journals. In: Altman DG, Machin D, Bryant TN, Gardner MJ (eds). Statistics with Confidence: Confidence Intervals and Statistical Guidelines. 2nd edition. BMJ Books, London, 2000, pp 171-190.
260. Rigby AS, Vail A. Statistical methods in epidemiology. II: A common sense approach to sample size estimation. Disabil Rehabil 1998; 20:405-410.
261. Schulz KF, Grimes DA. Sample size calculations in randomized trials: Mandatory and mystical. Lancet 2005; 365:1348-1353.
262. Drescher K, Timm J, Jockel KH. The design of case-control studies: The effect of confounding on sample size requirements. Stat Med 1990; 9:765-776.
263. Devine OJ, Smith JM. Estimating sample size for epidemiologic studies: The impact of ignoring exposure measurement uncertainty. Stat Med 1998; 17:1375-1389.
264. Olsen J, Basso O. Re: Residual confounding. Am J Epidemiol 1999; 149:290.
265. Slama R, Werwatz A. Controlling for continuous confounding factors: non- and semiparametric approaches. Rev Epidemiol Sante Publique 2005; 53:2S65-S280.
266. Greenland S. Introduction to regression modelling. In: Rothman KJ, Greenland S (eds). Modern Epidemiology. 2nd ed. Lippincott Raven, Philadelphia 1998, pp 401-432.
267. Thompson WD. Statistical analysis of case-control studies. Epidemiol Rev 1994; 16:33-50.
268. Schlesselman JJ. Logistic Regression for Case-Control Studies. Case-Control Studies Design, Conduct, Analysis. Oxford University Press, New York, 1982, pp 235-241.
269. Vickers AJ. Parametric versus non-parametric statistics in the analysis of randomized trials with non-normally distributed data. BMC Med Res Methodol 2005; 5:35.
270. Altman DG. Practical Statistics for Medical Research. Chapman and Hall, London, 1991.
271. Jekel JF, Katz DL, Elmore JG. Epidemiology, Biostatistics and Preventive Medicine. WB Saunders Company, Philadelphia, 2001.
272. Heeren T, D'Agostino R. Robustness of the two independent samples t-test when applied to ordinal scaled data. Stat Med 1987; 6:79-90.
273. Zimmerman DW, Zumbo BD. The effect of outliers on the relative power of parametric and nonparametric statistical tests. Perceptual Mot Skills 1990; 71:339-349.
274. Sawilowsky SS, Blair RC. A more realistic look at the robustness and Type II error properties of the t-test to departures from population normality. Psychological Bulletin 1992; 111:352-360.
275. Bridge PD, Sawilowsky SS. Increasing physicians' awareness of the impact of statistics on research outcomes: Comparative power of the t-test and Wilcoxon Rank-Sum test in small samples applied research. J Clin Epidemiol 1999; 52:229-235.
276. Senn S. Statistical Issues in Drug Development. John Wiley & Sons Ltd, Chichester, 1997.
277. Vickers AJ. The use of percentage change from baseline as an outcome in a controlled trial is statistically inefficient: A simulation study. BMC Med Res Methodol 2001; 1:6.
278. Feinstein AR. P-values and confidence intervals: Two sides of the same unsatisfactory coin. J Clin Epidemiol 1998; 51:355-360.
279. Hoffman RG, Lim JH. Observational study design. In: Ambrosius WT (ed). Methods in Molecular Biology, vol 404: Topics in Biostatistics. Humana Press Inc., Totowa, NJ, 2007, pp 19-31.
280. Fisher R. Statistical Methods and Scientific Inference. 3rd ed. Macmillan, New York, 1973.
281. Freeman PR. The role of p-values in analysing trial results. Stat Med 1993; 12:1443-1552.
282. Berkson J. Tests of significance considered as evidence. Journal of the American Statistical Association 1942; 37:325-335. Int J Epidemiol 2003; 32:687-691.
283. Altman DG. Confidence intervals in research evaluation. Ann Intern Med 1992; 116:A28-A29.
284. Simon R. Confidence intervals for reporting results of clinical trials. Ann Intern Med 1986; 105:429-435.
285. Kahn HA, Sempos CT. Statistical Methods in Epidemiology. Oxford University Press, Oxford, 1990.
286. Gøtzsche PC. Believability of relative risks and odds ratios in abstracts: Cross sectional study. BMJ 2006; 333: 231-234.
287. Wang R, Lagakos SW, Ware JH, Hunter DJ, Drazen JM. Statistics in medicine - reporting of subgroup analyses in clinical trials. N Engl J Med 2007; 357:2189-2194.
288. Rothwell PM. Treating individuals 2. Subgroup analysis in randomized controlled trials: Importance, indications, and interpretation. Lancet 2005; 365:176-186.
289. Hernández A, Boersma E, Murray G, Habbema J, Steyerberg E. Subgroup analyses in therapeutic cardiovascular clinical trials: Are most of them misleading? Am Heart J 2006; 151:257-264.
290. Lagakos SW. The challenge of subgroup analyses - reporting without distorting. N Engl J Med 2006; 354:1667-1669.
291. Bossuyt PM, Reitsma JB, Bruns DE, Gatsonis CA, Glasziou PP, Irwig LM; Standards for Reporting of Diagnostic Accuracy. Towards complete and accurate reporting of studies of diagnostic accuracy: The STARD Initiative. Ann Intern Med 2003; 138:40-44.
292. Haynes RB, Mulrow CD, Huth EJ, Altman DG, Gardner MJ. More informative abstracts revisited. Ann Intern Med 1990; 113:69-76.
293. Hartley J, Sydes M. Which layout do you prefer? An analysis of readers' preferences for different typographic layouts of structured abstracts. J Inf Sci 1996; 22:27-37.
294. Taddio A, Pain T, Fassos FF, Boon H, Ilersich AL, Einarson TR. Quality of nonstructured and structured abstracts of original research articles in the British Medical Journal, the Canadian Medical Association Journal and the Journal of the American Medical Association. CMAJ 1994; 150:1611-1615.
295. Hartley J, Sydes M, Blurton A. Obtaining information accurately and quickly: Are structured abstracts more efficient? J Inf Sci 1996; 22:349-356.
296. American Journal of Epidemiology. Information for authors. www.oxfordjournals.org/aje/for_authors/index.html
297. Sturmer T, Brenner H. Flexible matching strategies to increase power and efficiency to detect and estimate gene-environment interactions in case-control studies. Am J Epidemiol 2002; 155:593-602.
298. Becher H. The concept of residual confounding in regression models and some applications. Stat Med 1992; 11:1747-1758.
299. Brenner H, Blettner M. Controlling for continuous confounders in epidemiologic research. Epidemiology 1997; 8:429-434.
300. Altman DG, Lausen B, Sauerbrei W, Schumacher M. Dangers of using "optimal" cutpoints in the evaluation of prognostic factors. J Natl Cancer Inst 1994; 86:829-835.
301. Royston P, Altman DG, Sauerbrei W. Dichotomizing continuous predictors in multiple regression: A bad idea. Stat Med 2006; 25:127-141.
302. Vach W, Blettner M. Biased estimation of the odds ratio in case-control studies due to the use of ad hoc methods of correcting for missing values for confounding variables. Am J Epidemiol 1991; 134:895-907.
303. Little RJ, Rubin DB. A taxonomy of missing-data methods. In: Statistical Analysis with Missing Data, 2nd Edition. John Wiley & Sons, Hoboken, 2002, pp 19-23.
304. Rubin DB. Inference and missing data. Biometrika 1976; 63:581-592.
305. Rothman KJ, Greenland S. Basic methods for sensitivity analysis and external adjustment. In: Rothman KJ, Greenland S (eds). Modern Epidemiology, 2nd ed. Lippincott Williams & Wilkins, Philadelphia, 1998, pp 343-357.
306. Custer B, Longstreth WT Jr, Phillips LE, Koepsell TD, Van Belle G. Hormonal exposures and the risk of intracranial meningioma in women: A population-based case-control study. BMC Cancer 2006; 6:152.
307. Dunn NR, Arscott A, Thorogood M. The relationship between use of oral contraceptives and myocardial infarction in young women with fatal outcome, compared to those who survive: Results from the MICA case-control study. Contraception 2001; 63:65-69.
308. Wakefield MA, Chaloupka FJ, Kaufman NJ, Orleans CT, Barker DC, Ruel EE. Effect of restrictions on smoking at home, at school, and in public places on teenage smoking: cross sectional study. BMJ 2000; 321:333-337.
309. Greenland S. The impact of prior distributions for uncontrolled confounding and response bias: A case study of the relation of wire codes and magnetic fields to childhood leukemia. J Am Stat Assoc 2003; 98:47-54.
310. Lash TL, Fink AK. Semi-automated sensitivity analysis to assess systematic errors in observational data. Epidemiology 2003; 14:451-458.
311. Phillips CV. Quantifying and reporting uncertainty from systematic errors. Epidemiology 2003; 14:459-466.
312. Sheiner LB, Rubin DB. Intention-to-treat analysis and the goals of clinical trials. Clin Pharmacol Ther 1995; 57:6-15.
313. Nagelkerke N, Fidler V, Bernsen R, Borgdorff M. Estimating treatment effects in randomized clinical trials in the presence of non-compliance. Stat Med 2000; 19:1849-1864.
314. Ruiz-Canela M, Martinez-Gonzalez MA, de Irala-Estevez J. Intention to treat analysis is related to methodological quality. BMJ 2000; 320:1007-1008.
315. Armitage P, Colton T. Encyclopedia of Biostatistics. John Wiley & Sons, New York, 1998.
316. Committee for Proprietary Medicinal Products (CPMP). Points to Consider on Missing Data: The European Agency for the Evaluation of Medicinal Products. London, 2001.
317. Schulz KF, Grimes DA. Case-control studies: research in reverse. Lancet 2002; 359:431-434.
318. Hay AD, Wilson A, Fahey T, Peters TJ. The duration of acute cough in pre-school children presenting to primary care: A prospective cohort study. Fam Pract 2003; 20:696-705.
319. Dales LG, Ury HK. An improper use of statistical significance testing in studying covariables. Int J Epidemiol 1978; 7:373-375.
320. Maldonado G, Greenland S. Simulation study of confounder-selection strategies. Am J Epidemiol 1993; 138:923-936.
321. Rothman KJ, Greenland S. Precision and validity in epidemiologic studies. In: Rothman KJ, Greenland S (eds). Modern Epidemiology, 2nd ed. Lippincott Williams & Wilkins, Philadelphia, 1998, pp 120-125.
322. Mastrangelo G, Fedeli U, Fadda E, Valentini F, Agnesi R, Magarotto G, Marchi T, Buda A, Pinzani M, Martines D. Increased risk of hepatocellular carcinoma and liver cirrhosis in vinyl chloride workers: Synergistic effect of occupational exposure with alcohol intake. Environ Health Perspect 2004; 112:1188-1192.
323. Salo PM, Arbes SJ Jr, Sever M, Jaramillo R, Cohn RD, London SJ, Zeldin DC. Exposure to Alternaria alternata in US homes is associated with asthma symptoms. J Allergy Clin Immunol 2006; 118:892-898.
324. Pocock SJ, Clayton TC, Altman DG. Survival plots of time-to-event outcomes in clinical trials: Good practice and pitfalls. Lancet 2002; 359:1686-1689.
325. Sasieni P. A note on the presentation of matched case-control data. Stat Med 1992; 11:617-620.
326. Lee GM, Neutra RR, Hristova L, Yost M, Hiatt RA. A nested case-control study of residential and personal magnetic field measures and miscarriages. Epidemiology 2002; 13:21-31.
327. Greenland S, Neutra R. Control of confounding in the assessment of medical technology. Int J Epidemiol 1980; 9:361-367.
328. Robins JM. Data, design, and background knowledge in etiologic inference. Epidemiology 2001; 12:313-320.
329. Rockhill B, Newman B, Weinberg C. Use and misuse of population attributable fractions. Am J Public Health 1998; 88:15-19.
330. Uter W, Pfahlberg A. The application of methods to quantify attributable risk in medical practice. Stat Methods Med Res 2001; 10:231-237.
331. Schwartz LM, Woloshin S, Dvorin EL, Welch HG. Ratio measures in leading medical journals: Structured review of accessibility of underlying absolute risks. BMJ 2006; 333:1248.
332. Nakayama T, Zaman MM, Tanaka H. Reporting of attributable and relative risks, 1966-97. Lancet 1998; 351:1179.
333. Hess DR. How to write an effective discussion. Respir Care 2004; 49:1238-1241.
334. Horton R. The hidden research paper. JAMA 2002; 287:2775-8277.
335. Annals of Internal Medicine. Information for authors. www.annals.org.
336. Horton R. The rhetoric of research. BMJ 1995; 310:985-987.
337. Docherty M, Smith R. The case for structuring the discussion of scientific papers. BMJ 1999; 318:1224-1225.
338. Perneger TV, Hudelson PM. Writing a research article: Advice to beginners. Int J Qual Health Care 2004; 16:191-192.
339. Purcell GP, Donovan SL, Davidoff F. Changes to manuscripts during the editorial process: Characterizing the evolution of a clinical paper. JAMA 1998; 280:227-228.
340. Kiviluoto T, Sirén J, Luukkonen P, Kivilaakso E. Randomised trial of laparoscopic versus open cholecystectomy for acute and gangrenous cholecystitis. Lancet 1998; 351:321-325.
341. Maldonado G, Poole C. More research is needed. Ann Epidemiol 1999; 9:17-18.
342. Phillips CV. The economics of "more research is needed." Int J Epidemiol 2001; 30:771-776.
343. Poole C, Peters U, Il'yasova D, Arab L. Commentary: This study failed? Int J Epidemiol 2003; 32:534-535.
344. Campbell DT. Factors relevant to the validity of experiments in social settings. Psychol Bull 1957; 54:297-312.
345. Justice AC, Covinsky KE, Berlin JA. Assessing the generalizability of prognostic information. Ann Intern Med 1999; 130:515-524.
346. Uniform requirements for manuscripts submitted to biomedical journals. International Committee of Medical Journal Editors. N Engl J Med 1997; 336:309-315.
347. Krimsky S, Rothenberg LS. Conflict of interest policies in science and medical journals: Editorial practices and author disclosures. Sci Eng Ethics 2001; 7:205-218.
348. Bekelman JE, Li Y, Gross CP. Scope and impact of financial conflicts of interest in biomedical research: A systematic review. JAMA 2003; 289:454-465.
349. Davidson RA. Source of funding and outcome of clinical trials. J Gen Intern Med 1986; 1:155-158.
350. Lexchin J, Bero LA, Djulbegovic B, Clark O. Pharmaceutical industry sponsorship and research outcome and quality: Systematic review. BMJ 2003; 326:1167-1170.
351. Barnes DE, Bero LA. Industry-funded research and conflict of interest: An analysis of research sponsored by the tobacco industry through the Center for Indoor Air Research. J Health Polit Policy Law 1996; 21:515-542.
352. Boyd EA, Bero LA. Improving the use of research evidence in guideline development: 4. Managing conflicts of interest. Health Res Policy Syst 2006; 4:16.
353. Higgins P, Orris P. Providing employer arranged occupational medical care: Conflicting interests. Occup Med 2002; 17:601-606.
354. Safer DJ. Design and reporting modifications in industry-sponsored comparative psychopharmacology trials. J Nerv Ment Dis 2002; 190:583-592.
355. Aspinall RL, Goodman NW. Denial of effective treatment and poor quality of clinical information in placebo controlled trials of ondansetron for postoperative nausea and vomiting: A review of published trials. BMJ 1995; 311:844-846.
356. Chan AW, Hrobjartsson A, Haahr MT, Gøtzsche PC, Altman DG. Empirical evidence for selective reporting of outcomes in randomized trials: Comparison of protocols to published articles. JAMA 2004; 291:2457-2465.
357. Melander H, Ahlqvist-Rastad J, Meijer G, Beermann B. Evidence b(i)ased medicine - selective reporting from studies sponsored by pharmaceutical industry: Review of studies in new drug applications. BMJ 2003; 326:1171-1173.
358. Scherer RW, Langenberg P, von Elm E. Full publication of results initially presented in abstracts. Cochrane Database Syst Rev 2007; MR000005.